A patient with a 30-year history of somnambulism and night terrors is described. The use of a home ambulatory sleep electroencephalogram (EEG) record'mg in clarifying the diagnosis and in monitoring the results of treatment is illustrated and successful treatment using a selective serotonin re-uptake inhibitor is reported.
B is a 46-year-old retail manageress referred with severe sleep disturbance. She had recurrentepisodes of waking at night shouting, feeling very frightened,and being unable to recall what had awakened her. These occurred every night, often two or three times in the first few hours of sleep. Her partner reported that they were sometimes associated with sleep-walking. B had been adopted by kind but rather overprotective parents.She was a nervouschild who regularlysleep-walked up to the age of 14 years, when her sleep pattern became normalised. In her 20s, during a turbulent marriage, her sleep disturbance returned. She experienced poor sleep with frequent awakenings in a state of fear, together with episodes ofsleep-walking, during whichsheinjured herself on a number of occasions. As the marriage deteriorated thesleep disturbance becamemore severe and B was prescribed lorazepam, which produced some relief. The couple eventually separated and there was a further improvement in her sleep pattern, with an average of only two or three disturbed nights a week. She remained on lorazepam for the next 14 years, switching 2 years ago to diazepam on her general practitioner's advice after expressinga wish to come off benzodiazepines. Six months before referral she became engaged to a new partner and she found that hersleepdisturbance,particularlythe waking in terror and sleep-walking, interfered with the relationship.
At this time she reduced her diazepam to 1 mg twice daily, but on further reducing the dose to 1 mg of diazepam a day she experienced severe withdrawal symptoms of sweating and malaise, with an increasein the frequency of disturbednights.On re-instatingthe 1mgtwice-daily dosage the somatic symptoms resolved, but the night terrors persisted; at this stage she was referred for a psychiatric opinion concerning her sleep disturbance.
At assessment her sleep patternwas as follows: she went tobed at22.00 h and wouldtake10-60 minutes tofall asleep. She awoke one to fourtimesmost nights with feelings of extreme fear associated with shortness of breath, racing heart, and marked sweating. When awoken by her partner during an episode, she would be confused and wouldhaveno memoryof the event.Shewouldfeelgroggy andunrefreshed inthemorning, andinthelast fewweeks hadexperienced increasing difficulty incoping withday to-day stress and poorconcentration. A differential diagnosis of night terrors or possibly nocturnal panic attacks was made. To evaluate this and eliminate the possibility that they were nightmares we peformed a sleep recording in her own home ( Fig.  1(a) ). During this recording she had three terrors, and her partner marked the recording each time. There were many additional periods of waking during the night, mostly of short duration.
The most striking feature of this recording was that each time the patient started to fall into slow-wave sleep she had a terror with waking, and this appeared to abort the slow-wave sleep. As a result there was a paucity of slow-wave sleep, which amounted to only 3 minutes during the nightapproximately 20â€"30 minutes would be expected in this terrors. An increasedrapid eyemovement(REM)latency of 270 minutes was observed. After 3 months of sustained improvement her clonazepam was withdrawn uneventfully by tapering the dose over 4 weeks. A further 3 weeks later another sleep study was performed (Fig 1(b) identified at the time of occurrence -the patients said that they were so panic-stricken and confused that they had not remembered to call the technician. On balance, given the associated history of sleep-walking and absence of daytime panics, we felt that this lady had night terrors rather than nocturnal panic attacks.
The 
Treatment
Our working hypothesis was that of an underlying sleep disorder since adolescence, which had been partially treated with benzodiazepines. It was exacerbated at times of stress, or reduction in benzodiazepines, and this resulted in B increasing her alcohol consumption.
Benzodiazepines and alcohol act to enhance the GABAergic activity -the major inhibitory neurotransmitter in the brain â€"¿ but adaptive changes in this system lead to problems on withdrawal (Cowen & Nutt, 1982 insomnia that is proportional to the degree of brain serotonin depletion (Petitjean eta!, 1978) , which can be reversed by serotonin precursors such as trypto phan. There is also evidence from animal and human studies that serotonin is involved in the control of slow-wave sleep and that serotonin receptor subtypes may mediate different aspects of sleep and wakeful ness (Sharpley & Idzikowski, 1991) . However, there appear to have been no specific studies on the use of SSRIs for the treatment of sleep disorders, although they do normalise the REM advance seen in de pression. This case illustrates an interesting paradox in that, at least in volunteer studies, the SSRIs tend to decrease sleep continuity (Nicholson & Pascoe, 1986) , whereas in this case the patient's sleep was improved.
Clonazepam was substituted for her diazepam because it is recognised that there is often an increase in subjective anxiety and sleep disturbance on first commencing treatment with SSRIs. Clinically, we have found that by using a small dose of clonazepam these effects are minimised, and withdrawal, once the patient has become established on the SSRI, has not proved to be a problem to date. The possibility that paroxetine alone would have been effective might be worth evaluating in the future.
In summary, we report the use of domiciliary sleep recording in diagnosing a case of marked night terrors with sleep-walking. This patient was treated very successfully with a combination of a benzodiazepine and an SSRI and is currently in a period of prolonged remission on the SSRI alone.
